Travis Young, Calibr VP of biologics (Scripps)
Four years in the making, AbbVie and Calibr provide first look into ‘switchable’ CAR-T program
In 2018, AbbVie and Calibr — a branch of Scripps Research Institute — announced a partnership for a next-gen CAR-T program, then still in its preclinical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.